Massive Esophagogastric Variceal Bleeding from Chronic Portal Vein Thrombosis in a Non-Cirrhotic Young Man: A Resource-Limited Endoscopic Management Dilemma Authors: Osman Ahmed Tahajud, Omar Hassan Ahmed Published: 2026 ABSTRACT AbstractIntroductionVariceal upper gastrointestinal bleeding is a life-threatening manifestation of portal hypertension. Chronic portal vein thrombosis can cause clinically significant noncirrhotic portal hypertension with esophagogastric varices, and management is particularly challenging in resource-limited settings when definitive endoscopic or radiologic therapy is unavailable.Case PresentationA 31-year-old man presented with massive hematemesis, melena, loss of consciousness, and hemorrhagic shock. Hemoglobin was 3.5 g/dL. He was stabilized with crystalloid resuscitation, packed red blood cell transfusion, octreotide infusion, proton pump inhibitor therapy during the initial undifferentiated upper gastrointestinal bleeding phase, and antibiotics. Upper gastrointestinal endoscopy showed four large esophageal variceal columns with red color signs and evidence of recent bleeding, together with a large fundal gastroesophageal varix type 2 (GOV2) with evidence of recent bleeding. Because the recently bleeding GOV2 was considered the immediate therapeutic priority and definitive gastric-variceal therapy was unavailable locally, immediate esophageal band ligation was deferred. Urgent referral for definitive gastric-variceal therapy was arranged, with staged esophageal variceal ligation planned thereafter. Contrast-enhanced computed tomography showed chronic portal vein thrombosis with cavernous transformation, collateral vessels, splenomegaly, and ascites, with preserved hepatic morphology and no radiologic features of cirrhosis, supporting noncirrhotic portal hypertension. He was discharged on hospital day 5 without early rebleeding.ConclusionThis case highlights the management dilemma posed by recently bleeding GOV2 gastric varices with advanced esophageal varices in chronic portal vein thrombosis. It illustrates the challenges of managing acute variceal hemorrhage in resource-limited settings and highlights the importance of prompt resuscitation, vasoactive therapy, antibiotics, careful endoscopic risk assessment, and timely referral when definitive gastric-variceal treatment is not locally available.Keywords: noncirrhotic portal hypertension, cavernous transformation, hematemesis, gastrointestinal endoscopy, variceal hemorrhage, case report Introduction Acute variceal bleeding is a major gastrointestinal emergency with substantial morbidity and mortality. Cirrhosis is the most frequent cause of portal hypertension, but noncirrhotic causes such as chronic portal vein thrombosis (PVT) should be considered in younger patients without biochemical or clinical evidence of advanced liver disease. Chronic PVT can lead to cavernous transformation of the portal vein, collateral vessel formation, splenomegaly, ascites, and esophagogastric varices.1–3 Bleeding from gastric varices may be severe and technically difficult to treat, especially when it occurs together with large esophageal varices. Standard acute care includes hemodynamic resuscitation, blood transfusion when indicated, vasoactive therapy, antibiotic prophylaxis, early endoscopy, and definitive endoscopic or radiologic therapy when available.4–6 In resource-limited settings, access to cyanoacrylate injection, endoscopic ultrasound-guided therapy, interventional radiology, or staged expert endoscopy may be delayed or unavailable, creating difficult decisions when high-risk gastric and esophageal varices coexist. We present a case of massive esophagogastric variceal bleeding due to chronic PVT in a young man without cirrhosis. Immediate esophageal band ligation was deferred because a recently bleeding gastric varix was considered the immediate therapeutic priority and definitive gastric-variceal therapy was not locally available. Case Presentation A 31-year-old man presented with massive upper gastrointestinal bleeding. He had experienced a similar episode of hematemesis approximately 10 years earlier while living in a rural village, but no medical records were available. Before admission, he had no known chronic medical illness. There was no history of alcohol use, pancreatitis, schistosomiasis, or family history of thrombotic disease. There were no clinical stigmata of chronic liver disease, and viral screening was negative. Two days before admission, he developed a small-volume episode of hematemesis while brushing his teeth. The next day, he had another episode associated with fatigue, dyspnea, and melena. On the day of admission, he developed massive hematemesis followed by loss of consciousness. He was initially taken to a nearby hospital, where he received 2 L of intravenous fluid and 1 unit of blood, with transient improvement. Approximately 2 hours later, he again became hypotensive and was transferred to our hospital. The clinical course is summarized in Table 1. Table 1Clinical TimelineTimeKey Event10 years earlierRemote episode of hematemesis; no records available.2 days before admissionSmall-volume hematemesis while brushing teeth.1 day before admissionRecurrent hematemesis with fatigue, dyspnea, and melena.Day of admissionMassive hematemesis with loss of consciousness; initial treatment at a nearby hospital.Hospital day 0Shock on arrival; aggressive resuscitation and blood transfusion.Hospital day 1Endoscopy showed Paquet class IV esophageal varices and a fundal GOV2 gastric varix with recent bleeding.Hospital days 1-5Octreotide infusion, intravenous PPI therapy, antibiotics, monitoring, and transfusion support.Hospital day 2Oral sips started.Hospital day 3Soft diet started.Hospital day 5Discharged stable; no rebleeding on early follow-up. Clinical Timeline On arrival, he was critically ill, semiconscious, and in hemorrhagic shock. His Glasgow Coma Scale score was 9/15, blood pressure was 60/35 mmHg, and pulse rate was elevated. He had marked pallor, cold extremities, melena on digital rectal examination, and mild splenomegaly on abdominal palpation. No focal neurologic deficit was evident after resuscitation. Immediate management included intravenous crystalloid resuscitation with 1 L of 0.9% sodium chloride, after which blood pressure improved to 100/50 mmHg. Packed red blood cell (PRBC) transfusion was continued, and the patient received a total of 5 units during the course of management, including the initial unit administered before transfer. Hemodynamic status improved, the pulse rate decreased to 94 beats/min, and no further hematemesis occurred after admission. Initial laboratory studies showed hemoglobin 3.5 g/dL, white blood cell count 9 x 10^9/L, and platelet count 100 x 10^9/L. Renal function was preserved, with serum creatinine 1.1 mg/dL and urea 45 mg/dL. Liver biochemistry showed alanine aminotransferase 22 U/L, aspartate aminotransferase 25 U/L, total bilirubin 1.1 mg/dL, direct bilirubin 0.1 mg/dL, gamma-glutamyl transferase 16 U/L, total protein 4.3 g/dL, and albumin 2.6 g/dL. Prothrombin time, international normalized ratio (INR), and partial thromboplastin time were within normal limits. Serum sodium was 141 mmol/L, potassium was 3.8 mmol/L, and lactate was 2.5 mmol/L initially, improving to 1 mmol/L after resuscitation. Serial hemoglobin values increased to 6 g/dL, 8.1 g/dL, 9 g/dL, and 10.1 g/dL by discharge. The patient was started on octreotide infusion at 50 micrograms/hour before endoscopy, and this was continued for 5 days. Intravenous proton pump inhibitor (PPI) therapy was administered during the initial management of acute UGI bleeding before a non-variceal source had been excluded. Because of a documented ceftriaxone allergy, amoxicillin-clavulanate was given as antibiotic therapy. Nonselective beta-blockers were withheld during admission because the resting pulse rate remained between 51 and 55 beats/min. Upper gastrointestinal (UGI) endoscopy performed on hospital day 1 showed four large tortuous esophageal variceal columns extending to the mid esophagus, with red color signs and evidence of recent bleeding (Figure 1). A large fundal gastric varix extending beyond the gastroesophageal junction along the fundus, with evidence of recent bleeding, was also seen (Figure 2). The pylorus and duodenum were normal. The endoscopic diagnosis was Paquet class IV esophageal varices and gastroesophageal varices type 2 (GOV2). Upper gastrointestinal endoscopy showing large esophageal varices with red color signs and evidence of recent bleeding. The arrow indicates the esophageal varices. Upper gastrointestinal endoscopy showing a fundal gastroesophageal varix type 2 (GOV2) with evidence of recent bleeding. The arrow indicates the GOV2 gastric varix. Immediate esophageal band ligation was deferred because the recently bleeding fundal GOV2 was considered the immediate therapeutic priority, while definitive therapy for gastric varices was not available locally. The team therefore prioritized hemodynamic stabilization, vasoactive therapy, antibiotic therapy, and close monitoring. Urgent referral for definitive gastric-variceal therapy was arranged, with staged endoscopic ligation of the esophageal varices planned thereafter. Contrast-enhanced abdominal computed tomography (CT) showed a normal-sized liver without a focal lesion. Multiple tortuous enhancing collateral vessels were present at the porta hepatis and at the confluence of the splenic vein and superior mesenteric vein, consistent with cavernous transformation and portoportal collateralization (Figure 3). The main portal vein and intrahepatic portal branches were not visualized, consistent with chronic PVT or occlusion (Figure 4). The spleen was enlarged, measuring 13.2 cm, and moderate ascites was noted. Additional findings included splenic calcifications and bilateral wedge-shaped renal hypoenhancing areas suggestive of renal infarctions or ischemic perfusion defects (Figure 5). Overall, imaging supported chronic PVT with cavernous transformation and portal hypertensive changes. A formal etiologic evaluation for chronic PVT, including screening for myeloproliferative neoplasms such as JAK2 V617F mutation testing, antiphospholipid antibodies, protein C, protein S, antithrombin III, factor V Leiden and prothrombin gene mutations where available, paroxysmal nocturnal hemoglobinuria testing when indicated, and evaluation for local inflammatory or infective abdominal causes, was planned but was not available during the acute admission. Anticoagulation was not initiated during hospitalization because of the recent life-threatening variceal hemorrhage and the presence of untreated high-risk gastric and esophageal varices; reassessment was planned after definitive variceal control and specialist evaluation. Axial contrast-enhanced computed tomography (CECT) showing multiple collateral veins at the porta hepatis and at the confluence of the splenic vein and superior mesenteric vein, consistent with cavernous transformation/portoportal collateralization. Coarse splenic parenchymal calcifications are also present. The arrows indicate the cavernous collaterals and splenic calcifications. Axial venous-phase contrast-enhanced computed tomography (CECT) showing non-opacification of the main portal vein and its intrahepatic branches, consistent with chronic portal vein thrombosis. The arrow indicates the expected course of the non-opacified portal vein. Coronal contrast-enhanced computed tomography (CECT) showing bilateral wedge-shaped areas of renal parenchymal hypoenhancement, suggestive of renal infarctions or ischemic perfusion defects. The arrows indicate the renal perfusion defects. The patient remained clinically stable after resuscitation, with no recurrent hematemesis during hospitalization. Oral sips were started on hospital day 2, followed by a soft diet on hospital day 3, which he tolerated well. He was discharged on hospital day 5 in stable condition with a hemoglobin level of 10.1 g/dL. On early follow-up, he remained stable with no reported rebleeding. Discussion This case demonstrates severe variceal hemorrhage caused by chronic PVT in the absence of cirrhosis. The clinical and radiologic findings supported noncirrhotic portal hypertension, including preserved liver enzymes, normal coagulation parameters, absence of chronic liver disease stigmata, negative viral screening, and CT evidence of portal vein occlusion with cavernous transformation in the setting of a structurally preserved liver. Although cirrhosis is the dominant cause of portal hypertension worldwide, chronic PVT is an important alternative cause, particularly in younger patients. Chronic obstruction of portal venous flow promotes collateral vessel formation and can lead to clinically significant portal hypertension with splenomegaly, ascites, and variceal development.1–3 In the present case, both advanced esophageal varices and a fundal gastric varix had endoscopic signs of recent bleeding, explaining the severity of the presentation and the profound anemia at admission. The most distinctive feature of this case was the endoscopic management dilemma. The patient had large esophageal varices together with a recently bleeding fundal gastric varix. Immediate ligation of the esophageal varices was avoided because the recently bleeding GOV2 was considered the immediate therapeutic priority and definitive gastric-variceal therapy was unavailable locally. The management approach therefore emphasized stabilization and urgent referral for definitive gastric-variceal treatment, with staged esophageal variceal ligation planned thereafter, rather than implying that definitive gastric-variceal therapy was performed during the index admission. The patient presented in hemorrhagic shock with hypotension, reduced consciousness, melena, and an admission hemoglobin level of 3.5 g/dL. Rapid resuscitation with intravenous fluid and PRBC transfusion was essential. Octreotide was used as vasoactive therapy to reduce portal pressure, while antibiotics were administered as part of acute variceal bleeding care. Intravenous PPI therapy was used during the initial undifferentiated UGI bleeding phase and should not be considered definitive therapy for variceal hemorrhage. Although ceftriaxone is often used in this setting, amoxicillin-clavulanate was selected because of documented allergy. The absence of further hematemesis after stabilization highlights the importance of early supportive care when definitive therapy is delayed. This case is especially relevant to resource-limited environments. Gastric variceal bleeding is often more difficult to manage than isolated esophageal variceal bleeding and may require cyanoacrylate injection, endoscopic ultrasound-guided therapy, thrombin injection, balloon-occluded retrograde transvenous obliteration, or transjugular intrahepatic portosystemic shunt depending on the anatomy, local expertise, and available equipment.4–6 When these options are unavailable, initial medical stabilization becomes the critical bridge to safe referral. The additional CT findings of splenic calcifications and bilateral wedge-shaped renal hypoenhancing lesions raised concern for an underlying thrombotic predisposition or prior ischemic events. Ideally, evaluation should include assessment for myeloproliferative neoplasms, antiphospholipid syndrome, inherited thrombophilias, paroxysmal nocturnal hemoglobinuria when clinically indicated, and local abdominal inflammatory or infective causes. In this patient, thrombophilia testing and specialist hepatology/hematology workup were not available during the acute admission. Anticoagulation was deferred because of the recent massive variceal bleeding and untreated high-risk varices; however, it should be reconsidered after variceal control, once the bleeding risk and thrombotic risk can be reassessed. The principal limitations of this report are the single-case design, short follow-up duration, absence of definitive gastric-variceal treatment at the time of writing, and limited access to thrombophilia testing, specialist hepatology/hematology evaluation, and interventional radiology. These limitations should be considered when interpreting the management decisions and the early outcome. This report is presented in accordance with CARE guideline principles to enhance transparency and clinical interpretability.7 Conclusion Chronic portal vein thrombosis is an important cause of noncirrhotic portal hypertension and may present with massive esophagogastric variceal bleeding. When a recently bleeding GOV2 fundal gastric varix coexists with advanced esophageal varices, immediate endoscopic management may pose a therapeutic dilemma, particularly where definitive gastric-variceal therapy is unavailable. This case illustrates the management challenges encountered in resource-limited settings and highlights the importance of prompt resuscitation, vasoactive therapy, antibiotic therapy, careful endoscopic risk assessment, and timely referral when definitive gastric-variceal treatment is not locally available. Acknowledgments This Study was supported by SIMAD university, Mogadishu, Somalia. Abbreviations CT, computed tomography; GOV2, gastroesophageal varices type 2; INR, international normalized ratio; PPI, proton pump inhibitor; PRBC, packed red blood cell; PVT, portal vein thrombosis; UGI, upper gastrointestinal. Data Sharing Statement All relevant clinical data are contained within this article. Additional deidentified details are available from the corresponding author on reasonable request, subject to protection of patient confidentiality. Ethics and Consent Written informed consent was obtained from the patient for publication of this case report and the accompanying images. According to the policy of Dr. Sumait Hospital, formal ethics committee approval was not required for publication of a single-patient anonymized case report. Author Contributions All the authors made a significant contribution to the work reported, whether in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising, or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article will be submitted; and agree to be accountable for all aspects of the work. Disclosure The authors declare no conflicts of interest in this work. References Associated Data Data Availability Statement All relevant clinical data are contained within this article. Additional deidentified details are available from the corresponding author on reasonable request, subject to protection of patient confidentiality.